{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:21:39Z","timestamp":1788236499194,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["K\/ZDS\/002936"],"award-info":[{"award-number":["K\/ZDS\/002936"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jtha.2025.06.003","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:19:26Z","timestamp":1749557966000},"page":"2903-2912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prothrombotic fibrin clot phenotype as a risk factor for persistent left ventricular thrombus following acute myocardial infarction"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9781-1202","authenticated-orcid":false,"given":"Krystian","family":"Mr\u00f3z","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Paszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3716-1724","authenticated-orcid":false,"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.06.003_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamacardio.2020.0652","article-title":"Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi","volume":"5","author":"Robinson","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jtha.2025.06.003_bib2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamacardio.2018.1086","article-title":"Left ventricular thrombus after acute myocardial infarction: screening, prevention, and treatment","volume":"3","author":"McCarthy","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jtha.2025.06.003_bib3","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/ehf2.14369","article-title":"Factors influencing left ventricular thrombus resolution and its significance on clinical outcomes","volume":"10","author":"Kim","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jtha.2025.06.003_bib4","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jacc.2020.01.057","article-title":"ACTION Study Group. Antithrombotic therapy for patients with left ventricular mural thrombus","volume":"75","author":"Lattuca","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.06.003_bib5","article-title":"Left ventricular thrombus recurrence after anticoagulation discontinuation","volume":"54","author":"Namjouyan","year":"2024","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jtha.2025.06.003_bib6","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.06.003_bib7","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/ehf2.12718","article-title":"Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus","volume":"7","author":"Iqbal","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jtha.2025.06.003_bib8","first-page":"429","article-title":"Direct oral anticoagulants versus vitamin K antagonists for patients with left ventricular thrombus: a systematic review and meta-analysis","volume":"131","author":"Chen","year":"2021","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.jtha.2025.06.003_bib9","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1161\/CIR.0000000000001092","article-title":"Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association","volume":"146","author":"Levine","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.06.003_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12959-023-00488-1","article-title":"A prediction model for left ventricular thrombus persistence\/recurrence: based on a prospective study and a retrospective study","volume":"21","author":"Yang","year":"2023","journal-title":"Thromb J"},{"key":"10.1016\/j.jtha.2025.06.003_bib11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.4070\/kcj.2018.0346","article-title":"Shape and mobility of a left ventricular thrombus are predictors of thrombus resolution","volume":"49","author":"Oh","year":"2019","journal-title":"Korean Circ J"},{"key":"10.1016\/j.jtha.2025.06.003_bib12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s12975-023-01165-1","article-title":"Neutrophil-activating peptide 2 as a novel modulator of fibrin clot properties in patients with atrial fibrillation","volume":"15","author":"Z\u0105bczyk","year":"2024","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.jtha.2025.06.003_bib13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1055\/s-0040-1718923","article-title":"Fibrinolysis in acute and chronic cardiovascular disease","volume":"47","author":"Kietsiriroje","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.06.003_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/cvr\/cvad017","article-title":"Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice","volume":"119","author":"Z\u0105bczyk","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jtha.2025.06.003_bib15","article-title":"Fibrin clot properties in coronary artery disease: new determinants and prognostic markers","volume":"131","author":"Larsen","year":"2021","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.jtha.2025.06.003_bib16","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/hrt.2010.192740","article-title":"Altered fibrin clot properties in patients with chronic heart failure and sinus rhythm: a novel prothrombotic mechanism","volume":"96","author":"Palka","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.jtha.2025.06.003_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11239-016-1344-5","article-title":"Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis","volume":"42","author":"Lau","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2025.06.003_bib18","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.amjcard.2019.01.007","article-title":"A prothrombotic state in patients with a history of left ventricular thrombus","volume":"123","author":"Z\u0105bczyk","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtha.2025.06.003_bib19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood-2017-07-798306","article-title":"Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study","volume":"131","author":"Cieslik","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.06.003_bib20","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/eurheartj\/ehy013","article-title":"Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy","volume":"39","author":"Sumaya","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.06.003_bib21","article-title":"Laboratory testing for fibrinogen disorders: from routine investigations to research studies","author":"Undas","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.06.003_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2020.103946","article-title":"Plasma fibrin clot proteomics in patients with acute pulmonary embolism: association with clot properties","volume":"229","author":"Bryk","year":"2020","journal-title":"J Proteomics"},{"key":"10.1016\/j.jtha.2025.06.003_bib23","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.thromres.2015.02.005","article-title":"Shotgun analysis of plasma fibrin clot-bound proteins in patients with acute myocardial infarction","volume":"135","author":"Suski","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.06.003_bib24","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s11239-024-02980-5","article-title":"Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide","volume":"57","author":"Sadowski","year":"2024","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2025.06.003_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2010-02-267740","article-title":"Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1","volume":"116","author":"Meltzer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.06.003_bib26","first-page":"178","article-title":"Decreased plasma fibrinolytic potential as a risk for venous and arterial thrombosis","volume":"43","author":"Lisman","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.06.003_bib27","article-title":"Novel factors affecting fibrin clot formation and their clinical implications","volume":"134","author":"Z\u0105bczyk","year":"2024","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.jtha.2025.06.003_bib28","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1161\/STROKEAHA.111.622217","article-title":"Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases","volume":"43","author":"Tj\u00e4rnlund-Wolf","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.06.003_bib29","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1016\/j.jtha.2023.06.017","article-title":"The prothrombotic tendency of metabolic-associated fatty liver disease","volume":"21","author":"Swan","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.06.003_bib30","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/ATVBAHA.119.312619","article-title":"Endothelial PAI-1 (plasminogen activator inhibitor-1) blocks the intrinsic pathway of coagulation, inducing the clearance and degradation of FXIa (activated factor XI)","volume":"39","author":"Puy","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.06.003_bib31","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1161\/01.ATV.16.10.1277","article-title":"High concentrations of active plasminogen activator inhibitor-1 in porcine coronary artery thrombi","volume":"16","author":"Fay","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.06.003_bib32","article-title":"High-dose atorvastatin and rosuvastatin reduce the levels of neutrophil extracellular trap-related proteins in coronary artery disease: association with prothrombotic state","volume":"134","author":"St\u0119pie\u0144","year":"2024","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.jtha.2025.06.003_bib33","first-page":"1205","article-title":"Neutrophil extracellular traps (NETs) in cardiovascular diseases: from molecular mechanisms to therapeutic interventions","volume":"81","author":"Natorska","year":"2023","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.jtha.2025.06.003_bib34","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41440-020-0527-9","article-title":"Emerging role of NET inhibitors in cardiovascular diseases","volume":"43","author":"Jayaseelan","year":"2020","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jtha.2025.06.003_bib35","first-page":"1135","article-title":"Enhanced complement consumption and histone H3 citrullination predict disease severity and early mortality risk in non-high-risk pulmonary embolism","volume":"82","author":"Rostoff","year":"2024","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.jtha.2025.06.003_bib36","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/eurheartj\/ehv419","article-title":"Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium","volume":"37","author":"Riegger","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.06.003_bib37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00441-017-2727-4","article-title":"Platelet\u2013neutrophil interactions as drivers of inflammatory and thrombotic disease","volume":"371","author":"Lisman","year":"2018","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jtha.2025.06.003_bib38","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/ATVBAHA.113.301627","article-title":"Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state","volume":"33","author":"Borissoff","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.06.003_bib39","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.1074\/jbc.M112.404301","article-title":"Mechanical stability and fibrinolytic resistance of clots containing fibrin, DNA, and histones","volume":"288","author":"Longstaff","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.06.003_bib40","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/ATVBAHA.119.312463","article-title":"Neutrophil extracellular traps: villains and targets in arterial, venous, and cancer-associated thrombosis","volume":"39","author":"Th\u00e5lin","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.06.003_bib41","article-title":"Citrullination in health and disease: from physiological function to gene regulation","volume":"12","author":"Zhang","year":"2024","journal-title":"Genes Dis"},{"key":"10.1016\/j.jtha.2025.06.003_bib42","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1038\/s41467-025-56978-5","article-title":"S100A12 triggers NETosis to aggravate myocardial infarction injury via the annexin A5\u2013calcium axis","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2025.06.003_bib43","article-title":"Etosis, rather than apoptosis or cell proliferation, typifies thrombus progression\u2014an immunohistochemical study of coronary aspirates","volume":"26","author":"Pertiwi","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jtha.2025.06.003_bib44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40478-025-01951-y","article-title":"Blocking peptidyl arginine deiminase 4 confers neuroprotective effect in the post-ischemic brain through both NETosis-dependent and -independent mechanisms","volume":"13","author":"Seol","year":"2025","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.jtha.2025.06.003_bib45","article-title":"The cardiac wound healing response to myocardial infarction","volume":"15","author":"Chalise","year":"2023","journal-title":"Wires Mech Dis"},{"key":"10.1016\/j.jtha.2025.06.003_bib46","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/rth2.12443","article-title":"Effect of anticoagulants on fibrin clot structure: a comparison between vitamin K antagonists and factor Xa inhibitors","volume":"4","author":"Gauer","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.06.003_bib47","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1538-7836.2010.03739.x","article-title":"Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor","volume":"8","author":"Ammollo","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.06.003_bib48","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2141.2010.08546.x","article-title":"Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate","volume":"152","author":"Blomb\u00e4ck","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.06.003_bib49","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.thromres.2015.08.007","article-title":"Vitamin K antagonists favourably modulate fibrin clot properties in patients with atrial fibrillation as early as after 3 days of treatment: relation to coagulation factors and thrombin generation","volume":"136","author":"Z\u0105bczyk","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.06.003_bib50","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1111\/jth.14281","article-title":"Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity","volume":"16","author":"Carter","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.06.003_bib51","article-title":"Plasma fibrin clots of pulmonary embolism patients present increased amounts of factor XIII and \u03b12-antiplasmin at 3 months\u2019 anticoagulation since the acute phase","volume":"71","author":"Z\u0105bczyk","year":"2020","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.jtha.2025.06.003_bib52","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/187152508784871990","article-title":"The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis","volume":"6","author":"Muszbek","year":"2008","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1016\/j.jtha.2025.06.003_bib53","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1002\/ehf2.14084","article-title":"Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus","volume":"9","author":"Huang","year":"2022","journal-title":"ESC Heart Fail"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625003617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625003617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:03:43Z","timestamp":1788235423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625003617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1538783625003617"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.06.003","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prothrombotic fibrin clot phenotype as a risk factor for persistent left ventricular thrombus following acute myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}